Ivantis

Ivantis is a company focused on developing innovative therapies for glaucoma. Their goal is to develop a less invasive and more effective option for the over 60 million people worldwide with primary open-angle glaucoma. Upon successfully achieving this initial objective, they plan to focus on advancing innovative treatments for other debilitating diseases within ophthalmology.